GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 269 filers reported holding GLOBUS MED INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $253,000 | -80.5% | 3,308 | -80.3% | 0.00% | -66.7% |
Q2 2021 | $1,299,000 | +403.5% | 16,753 | +300.8% | 0.00% | +200.0% |
Q1 2021 | $258,000 | -34.7% | 4,180 | -30.9% | 0.00% | 0.0% |
Q4 2020 | $395,000 | -8.6% | 6,050 | -30.6% | 0.00% | 0.0% |
Q3 2020 | $432,000 | -0.2% | 8,723 | -14.4% | 0.00% | -50.0% |
Q1 2020 | $433,000 | -42.6% | 10,187 | -20.6% | 0.00% | 0.0% |
Q4 2019 | $755,000 | +11.7% | 12,827 | -3.0% | 0.00% | 0.0% |
Q3 2019 | $676,000 | +4.3% | 13,222 | -13.7% | 0.00% | 0.0% |
Q2 2019 | $648,000 | -26.6% | 15,328 | -14.2% | 0.00% | -33.3% |
Q1 2019 | $883,000 | +13.5% | 17,868 | -0.6% | 0.00% | 0.0% |
Q4 2018 | $778,000 | -28.2% | 17,972 | -5.8% | 0.00% | -25.0% |
Q3 2018 | $1,083,000 | +11.4% | 19,072 | -1.0% | 0.00% | 0.0% |
Q2 2018 | $972,000 | -1.2% | 19,262 | -2.4% | 0.00% | 0.0% |
Q1 2018 | $984,000 | +8.0% | 19,742 | -10.9% | 0.00% | 0.0% |
Q4 2017 | $911,000 | -17.9% | 22,167 | -40.7% | 0.00% | -20.0% |
Q3 2017 | $1,110,000 | – | 37,362 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |